Skip to content

4Accepted Mar 25, 8:36 PM ET

Chevallard Daniel R. 4

LENZLENZ Therapeutics, Inc.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:36 PM

Mar 25, 2024

Filed

Mar 25, 2024

Documents

1

Size

6.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.